Two-Point Versus Single-Point Serratus Anterior Plane Block for Post-Thoracoscopic Surgery Analgesia

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorShiyou Wei

About this trial

Postoperative pain remains a common clinical challenge in patients undergoing video-assisted thoracoscopic surgery (VATS), impairing early recovery and increasing opioid consumption. The serratus anterior plane block (SAPB) is a widely used regional analgesic technique for thoracic surgery, but conventional single-point injection may have limited spread of local anesthetics, resulting in suboptimal analgesia in some patients. Preliminary anatomical evidence suggests that two-point combined SAPB may achieve wider dermatomal coverage and better analgesic efficacy.

This is a single-center, prospective observational cohort study conducted at Shanghai Pulmonary Hospital, China. A total of 88 adult patients scheduled for elective unilateral VATS will be consecutively enrolled and naturally assigned to either the two-point combined SAPB group (injection at the 3rd and 5th rib levels, total 30 ml local anesthetic) or the single-point SAPB group (injection at the 5th rib level, 30 ml local anesthetic) according to routine clinical practice.

The primary outcome is the verbal rating scale (VRS) pain score on coughing at 24 hours postoperatively. Secondary outcomes include resting and dynamic pain scores at multiple time points, cumulative opioid consumption at 24 and 48 hours, incidence of postoperative nausea and vomiting, block-related complications, length of hospital stay, and Quality of Recovery-15 (QoR-15) scores. This study aims to provide clinical evidence for optimizing perioperative analgesic strategies for thoracoscopic surgery.

Eligibility criteria

Qualifiers

Aged 18 to 85 years at enrollment, regardless of sex

American Society of Anesthesiologists (ASA) physical status grade I to III

Scheduled for elective unilateral video-assisted thoracoscopic surgery

Planned to receive ultrasound-guided SAPB for routine perioperative analgesia

Disqualifiers

Local infection or skin lesion at the block puncture site

Known hypersensitivity or allergy to amide local anesthetics

Preexisting sensory abnormality in the chest wall surgical area

Chronic opioid use for > 3 months, history of chronic pain syndrome, or history of opioid abuse

Trial design

Treatments tested in this trial

  • Two-Point Serratus Anterior Plane Block
  • Single-Point Serratus Anterior Plane Block

Treatment groups

88 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Shiyou Wei

Lead sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Sponsor institution